Kala Pharmaceuticals Inc. (KALA)
Director Bazemore Todd 🟢 acquired 180.0K shares (1 derivative) of KALA BIO, Inc. (KALA) at $11.22 ($2.0M) Transaction Date: Aug 29, 2025 | Filing ID: 086367
Director Bazemore Todd 🟢 acquired 180.0K shares (1 derivative) of KALA BIO, Inc. (KALA) at $11.22 ($2.0M) Transaction Date: Aug 29, 2025 | Filing ID: 086367
🔍 Bazemore Todd (Director)
Company: KALA BIO, Inc. (KALA)
Report Date: 2025-08-29
Transaction Summary:
Detailed Transactions and Holdings:
Date: 2025-08-29 | Code: A | Expires: 2035-08-28 | equity_swap_involved: 0 | shares_owned_after: 180,000.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes: